Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexmedetomidine for prevention of postoperative delirium in frail older adults undergoing complex arthroscopic shoulder surgery
ChiCTR2500100658Phase 4Completed
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoints: Regional cerebral oxygen saturation, Heart rate and 3 more. Started Apr 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2500100658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100658.